We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Scancell Holdings Plc | LSE:SCLP | London | Ordinary Share | GB00B63D3314 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.05 | 0.55% | 9.15 | 8.80 | 9.50 | 9.15 | 8.86 | 9.10 | 1,054,095 | 12:15:26 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.27M | -11.94M | -0.0129 | -7.09 | 84.9M |
Date | Subject | Author | Discuss |
---|---|---|---|
10/10/2017 09:28 | How does this morning's announcement make any difference whatsoever to questions that can be asked at the AGM? | bermudashorts | |
10/10/2017 09:23 | W.... do you really think that the BOD will allow that to happen, hence this mornings announcement. | tosh123 | |
10/10/2017 09:06 | Will you be asking RG awkward questions at the AGM, to test your theory? | wigwammer | |
10/10/2017 08:53 | B... yes i read it, and i stand by my post... Lets just see whether RG plays any role in todays AGM, other than to sit in the corner. And as for the funding / deals issue, i also think that had RG of secured anything meaningful, then the BOD would have allowed RG to take credit for that, prior to announcing his replacement... remember B, they have announced this in an RNS on the day of the AGM, which is still some 3 - 4 months before the new CEO takes up post. | tosh123 | |
10/10/2017 08:52 | How so Panama? - RG is 67 and is moving to a non-exec role. Standard stuff. | bermudashorts | |
10/10/2017 08:45 | Not before time, Panama, Tosh, Aimbig, Terror and a few others proved to be 100% correct but why has it taken so long. | panama7 | |
10/10/2017 08:44 | Tosh, did you actually read the RNS? "Scancell Holdings plc, ('Scancell' or the 'Company') the developer of novel immunotherapies for the treatment of cancer, is pleased to announce the appointment of Dr Cliff Holloway as Chief Executive Officer of Scancell, starting 10 January 2018" | bermudashorts | |
10/10/2017 08:36 | about time ! The only question now is about the timing of the RNS eg ;- does this mean that RG will now be shielded from having to answer any awkward questions about his performance at todays AGM ?.... mmmmmm What this also does is somewhat confirm that funding / JV's are still not sorted IMHO. If they were, then surely the BOD would have let RG see things through and take credit for any agreements. I think we're in trouble and JC has realised that, and has now given RG all the chances that he can, so has decided to get rid ( like some of us did a few years ago ). | tosh123 | |
10/10/2017 07:14 | GOODFELLOW must have been pushed. The gushing comments about his performance and contribution are a sure giveaway. LIndy and the rest of the Board have now realised how incompetent the Commercial performance has been. No doubt II's were pressing for change too. All except poor Torquay Fan who publishes a gushing post about his love for Goodfellow hours before his demise, Funny old game. | terror | |
10/10/2017 07:13 | Nice to see the grinning moron step aside | kreature | |
10/10/2017 07:08 | So AIMBIG was right all along. Having spotted the incompetence years ago, it is a surprise that it has taken this long to remove Goodfellow as Commercial Director. I have no idea why he is staying on the BofD, presumably for financial reasons buying out all his options. I suspect we will see a quiet drift away from the spotlight back to the potting shed where he belongs. | terror | |
10/10/2017 07:02 | GOODFELLOW REPLACED NOT BEFORE TIME | terror | |
10/10/2017 06:19 | It matters nothing what the Board have to say as it has been proven in the past that what they say is unreliable at the very best, generally misleading, lacking in strategic detail and some would say, just lies. Goodfellow has zero credibility. Anything that man says should be dismissed as fantasy. | terror | |
09/10/2017 01:15 | Aimbig, unfortunately your words often got caught up in your own manner of posturing and all that evolved with it. Was some statement to make four years ago, which just holds some credence now. I assume you were origanally talking about RGs initial plans, fair enough. An important AGM for the BOD including RG, lets hear what they have to say | chelsea35 | |
08/10/2017 23:26 | Chelsea. I have said for years as you know that Goodfellow was and still is a massive incompetent Commercial Director. My jibes about Potting Sheds had a serious element that you and others refused to believe, yet here we are years further on in a booming stock market and Scancell investors are under water, with little hope of making any profit. Goodfellow has lied, deceived, spun tales and misled investors. P7 is correct, nothing Goodfellow has said comes true, if he was a FTSE 100 CEO he would be in serious regulatory trouble. | terror | |
08/10/2017 02:59 | I agree with what you say P7, but if RG had sunk my investment over a period of 3-4 years with false promises, I'd make my feelings known at the AGM. To which I must ask are you going to do this, as banging on about RG on a BB with half a dozen contributors does not get the across the point you make | wanderer1210_0 | |
07/10/2017 21:47 | What proof other than Goodfellow's words do you have of a 2015 deal. The trials are most definitely a combined 4 years late. When the combi trial was announced we were told it would commence in 2016 and likewise Moditope was due to start in 2016. He told us in 2015 funding was easy for a company with a successful phase 2 trial behind it. What an absolute load of nonsense. The bloke has misled Investors for 5 years. He should be sacked for gross incompetence. | panama7 | |
07/10/2017 20:36 | panama7, was the 2015 deal that was never sealed "spin"?? The trials are not four years late. Beyond that as you know from my posts the last year, yes the jury is out. What/Who would you replace RG with? Criticism is easy, constructive criticism a lot harder. Anyway, goodnight. | chelsea35 | |
07/10/2017 20:15 | Chelsea, of course it's all spin, you had an email from Goodfellow stating everything is on track and going to plan when nothing could be further from the truth. Nothing is on track, trials are a total of 4 years late from their first original dates, there is no funding in place to pay for the trials, no deals and no sale. The bloke's incompetence is breathtaking, he tells you what you want to hear and you lap it up. you have held your shares for 5 years and if you needed your money tomorrow you would incur a massive loss and that is down to Goodfellow's failings | panama7 | |
07/10/2017 11:21 | panama7, I don"t actually refer to it as "spin". It is the opinion that is important, particularly now as some time has passed since you first stated it and was perhaps a bit premature. Just hoping we are in a better position now after a year of further clinical development to command deals or a raising at a mutually beneficial value. Not holding my breath, the lack or existence of buying pre AGM is noteworthy. | chelsea35 | |
07/10/2017 10:27 | Chelsea, Balerno only sounds like me because he is also questioning Goodfellow's performance which has simply not been good enough. Even you yourself after putting up with his spin, rhetoric and non delivery for 4 years are starting to think differently. Unless he pulls a rabbit out of the hat in the next 72 hours his time is up. | panama7 | |
06/10/2017 21:18 | goosed, and we all complained at raising at 17p lol !! ATB | chelsea35 | |
06/10/2017 17:14 | AGM 2016 - "Mindful" as Chiplin said he was of the previous to last cash raise being at 17p & then going out and scooping up approx. 1m Shs @ 10p when PI's were denied the same opportunity . . . . . I wonder if anyone attending this years jamboree will ask what value there is in having significant costs (US Office & BoD members) gnawing away at funds raised, yeup, right back here in old Blighty ? | gooosed |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions